Persistent URL of this record https://hdl.handle.net/1887/3277528
Documents
-
- Download
- 122263358_publishedVersion_None
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
NK cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
- All authors
- Gruijs, M.; Ganzevles, S.H.; Stigter-van Walsum, M.; Mast, R. van der; Ostaijen-ten Dam, M.M. van; Tuk, C.W.; Schilham, M.W.; Leemans, C.R.; Brakenhoff, R.H.; Egmond, M. van; Ven, R. van de; Bakema, J.E.
- Date
- 2021-10-01
- Volume
- 22
- Issue
- 20